Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2002; 40:93-99
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwartzman, D.
Right arrow Articles by Warman, E. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwartzman, D.
Right arrow Articles by Warman, E. N.

CLINICAL STUDY

early recurrence of atrial fibrillation after ambulatory shock conversion

David Schwartzman, MD FACC*,*, Shailesh Kumar Musley, PhD{dagger}, Charles Swerdlow, MD, FACC{ddagger}, Robert H. Hoyt, MD, FACC§ and Eduardo N. Warman, PhD{dagger}

* Atrial Arrhythmia Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
{dagger} Medtronic Inc., Minneapolis, Minnesota, USA
{ddagger} Cedars-Sinai Medical Center, Los Angeles, California, USA
§ Iowa Heart Center, Des Moines, Iowa, USA

Manuscript received October 11, 2001; revised manuscript received March 27, 2002, accepted April 5, 2002.

* Reprint requests and correspondence: Dr. David Schwartzman, Cardiovascular Institute, Presbyterian University Hospital, B535, 200 Lothrop Street, Pittsburgh, Pennsylvania 15213-2582, USA.
schwartzmand{at}msx.upmc.edu

OBJECTIVES: We sought to gain insights into the early recurrence of atrial fibrillation (ERAF) after cardioversion shocks delivered by permanently implanted rhythm management systems.

BACKGROUND: Several reports have characterized ERAF, but these reports used a limited definition and did not evaluate an association between clinical or device variables and ERAF.

METHODS: A total of 144 patients with recurrent, drug-resistant, symptomatic atrial fibrillation (AF) underwent implantation of an atrial rhythm management system (Medtronic Jewel AF, Model 7250, Minneapolis, Minnesota). The device was programmed to deliver cardioversion shocks automatically and/or on patient command. The incidence of ERAF was evaluated after 1,092 successful shocks among 97 patients. Three different ERAF definitions were used: recurrence within 1 min, 1 h or 1 day. Multiple clinical and device variables were assessed for their relationship with ERAF.

RESULTS: The per-patient incidences of ERAF were 44%, 61% and 70% for ERAF within 1 min, 1 h and 1 day, respectively. The per-episode incidences of ERAF were 17%, 30% and 43% for ERAF within 1 min, 1 h and 1 day, respectively. Variables that were independently associated with ERAF included AF duration <3 h before termination, more than one shock required to cardiovert and the absence of a previous myocardial infarction. The most potent variable was AF duration <3 h, associated with a threefold increase in the incidence of ERAF.

CONCLUSIONS: Recurrence of AF early after ambulatory shock cardioversion is common. In this retrospective study, both clinical and device variables were predictive.

Abbreviations and Acronyms
  AF
  atrial fibrillation
  CI
  confidence interval
  ERAF
  early recurrence of atrial fibrillation
  ERAF1 min
  successful shock followed by AF within 1 min
  ERAF1 h
  successful shock followed by AF within 1 h
  ERAF1 day
  successful shock followed by AF within 24 h
  GEE
  generalized estimating equation




This article has been cited by other articles:


Home page
EuropaceHome page
D. Schwartzman, M. N. Harvey, R. H. Hoyt, J. L. Koehler, M. R. Ujhelyi, and D. E. Euler
Utility of adjunctive single oral bolus propafenone therapy in patients with atrial defibrillators.
Europace, March 1, 2006; 8(3): 211 - 215.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. R.J. Mitchell
'The patient takes charge' -- long term use of the atrial defibrillator
Eur. Heart J., December 1, 2003; 24(23): 2075 - 2076.
[Full Text] [PDF]


Home page
Eur Heart JHome page
J.C. Geller, S. Reek, C. Timmermans, T. Kayser, H.-F. Tse, C. Wolpert, W. Jung, A.J. Camm, C.-P. Lau, H. J.J. Wellens, et al.
Treatment of atrial fibrillation with an implantable atrial defibrillator -- long term results
Eur. Heart J., December 1, 2003; 24(23): 2083 - 2089.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement